{
  "id": "13860c18dc0fa473",
  "title": "FinancialContent - ImmunityBio ( IBRX ): The Rise of Immunotherapy 2 . 0 and the Global Expansion of ANKTIVA",
  "description": "20260219T153000Z",
  "content": "",
  "source": "markets.financialcontent.com",
  "source_url": "https://markets.financialcontent.com/stocks/article/finterra-2026-2-19-immunitybio-ibrx-the-rise-of-immunotherapy-20-and-the-global-expansion-of-anktiva",
  "published_at": "20260219T153000Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://markets.financialcontent.com/stocks/article/finterra-2026-2-19-immunitybio-ibrx-the-rise-of-immunotherapy-20-and-the-global-expansion-of-anktiva",
    "url_mobile": "",
    "title": "FinancialContent - ImmunityBio ( IBRX ): The Rise of Immunotherapy 2 . 0 and the Global Expansion of ANKTIVA",
    "seendate": "20260219T153000Z",
    "socialimage": "https://news.finterra.ai/wp-content/uploads/2026/02/241495b5-e5bf-4546-b5ee-d974f10f5c5c-1024x683.png",
    "domain": "markets.financialcontent.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}